logo

Syndax Pharma (SNDX)



Trade SNDX now with
  Date
  Headline
12/9/2020 6:32:14 AM Syndax Reports Pricing Of Public Offering Of 5.43 Mln Common Shares At $23/Shr
7/7/2020 7:08:47 AM Syndax Pharma Appoints Daphne Karydas As CFOr, Effective July 13
5/22/2020 10:21:35 AM Stock Alert: Synadax Down 18%
4/30/2020 7:55:08 AM Syndax Pharma Says Prices Underwritten Public Offering Of 5.55 Mln Shares At $18/shr
1/31/2020 7:08:19 AM Syndax Announces $35 Mln Offering Of Common Stock And Enters Term Sheet For Loan With Hercules Capital For $30 Mln
12/10/2019 7:04:53 AM Syndax Pharma To Begin Phase 2 Expansion Cohort Of SNDX-6352 For Chronic Graft Versus Host Disease
7/10/2019 7:13:27 AM Syndax Pharma Says FDA Clearance Of IND Application To Begin A Phase 1/2 Trial For SNDX-5613 For R/R Acute Leukemias
5/28/2019 11:19:44 AM Sirnaomics Appoints Allan Shaw As CFO
4/1/2019 10:36:11 AM Syndax Pharmaceuticals Presents Updated Phase 2 Data From ENCORE 601 Trial Of Entinostat In Combination With KEYTRUDA